Serum salusin-alpha level in rheumatoid arthritis

Area of Science:

• Cardiovascular Research
• Rheumatology
• Biochemistry

Background:

• Rheumatoid arthritis (RA) accelerates atherosclerosis, but its mechanisms are unclear.
• Salusin-α and salusin-β are novel peptides with opposing roles in foam cell formation.
• Reduced salusin-α is linked to coronary artery disease.

Purpose of the Study:

• To evaluate serum salusin-α levels in RA patients.
• To investigate the association between salusin-α and atherosclerosis predictors in RA.
• To compare salusin-α levels and atherosclerosis markers in RA, Behcet's disease (BD), and healthy controls (HC).

Main Methods:

• Serum levels of TNF-α, IL-6, and salusin-α were measured.
• Homeostasis model assessment for insulin resistance (HOMA-IR) was calculated.
• Common carotid intima-media thickness (IMT) was assessed.

Main Results:

• Salusin-α and IMT were significantly higher in RA and BD groups compared to HC.
• No direct correlation was found between salusin-α levels and IMT across all groups.
• Elevated salusin-α in RA and BD did not correlate with increased IMT.

Conclusions:

• Serum salusin-α levels are elevated in RA and BD patients with increased IMT.
• Salusin-α's anti-atherogenic role may not directly apply to RA and BD pathogenesis.
• Further research is needed to clarify salusin-α regulation and its relationship with atherosclerosis predictors in RA and BD.